Greater Cannabis Co (Greater Cannabis Co) Growth Rank : 0 (As of Jun. 07, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Greater Cannabis Co Growth Rank?

Greater Cannabis Co has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Greater Cannabis Co Growth Rank Related Terms

Thank you for viewing the detailed overview of Greater Cannabis Co's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Greater Cannabis Co (Greater Cannabis Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Greater Cannabis Co Inc (OTCPK:GCAN) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

15 Walker Avenue, Suite 101, Baltimore, MD, USA, 21208

Website

https://www.gcanrx.com

Greater Cannabis Co Inc ia a biopharmaceutical company focused on the development and commercialization of innovative cannabinoid therapeutics. The firm focuses on cannabis-related investment and development opportunities through direct equity investments, joint ventures, licensing agreements, or acquisitions and also on commercializing its eluting transmucosal patch platform (ETP) technology. The company's operations are focused on its online store, GCC Superstore. The firm is involved in additional research and development of innovative cannabinoid-based therapeutics.

Executives

Jimmy Wayne Anderson

10 percent owner

501 1ST AVENUE NORTH, SUITE 901, ST. PETERSBURG FL 33701